Treatment of non-odontogenic orofacial pain using botulinum toxin-A: a retrospective case series study
Open Access
- 6 August 2018
- journal article
- review article
- Published by Springer Nature in Maxillofacial Plastic and Reconstructive Surgery
- Vol. 40 (1) , 21
Abstract
The purpose of this study was to evaluate the clinical outcomes of treatment of non-odontogenic atypical orofacial pain using botulinum toxin-A. This study involved seven patients (seven females, mean age 65.1 years) who had non-odontogenic orofacial pain (neuropathic pain and atypical orofacial pain) and visited the Seoul National University Bundang Hospital between 2015 and 2017. All medication therapies were preceded by botulinum toxin-A injections, followed by injections in the insignificant effects of medication therapies. Five of the seven patients received intraoral injections in the gingival vestibule or mucosa, while the remaining two received extraoral injections in the masseter and temporal muscle areas. In five of the seven patients, pain after botulinum toxin-A injection was significantly reduced. Most of the patients who underwent surgery for dental implantation or facial nerve reconstruction recovered after injections. However, the pain did not disappear in two patients who reported experiencing persistent pain without any cause. The use of botulinum toxin-A for the treatment of non-odontogenic neuropathic orofacial pain is clinically useful. It is more effective to administer botulinum toxin-A in combination with other medications and physical therapy to improve pain.Keywords
This publication has 17 references indexed in Scilit:
- Conversion Ratio between Botox®, Dysport®, and Xeomin® in Clinical PracticeToxins, 2016
- A clinical evaluation of botulinum toxin-A injections in the temporomandibular disorder treatmentMaxillofacial Plastic and Reconstructive Surgery, 2016
- Differential diagnosis of facial pain and guidelines for managementBritish Journal of Anaesthesia, 2013
- Efficacy and Safety of a Novel Botulinum Toxin Type A Product for the Treatment of Moderate to Severe Glabellar Lines: A Randomized, Double-Blind, Active-Controlled Multicenter StudyDermatologic Surgery, 2013
- Low Level Laser Therapy for the Treatment of Temporomandibular Disorders: A Systematic Review of the LiteratureCranio®, 2012
- A double-blind, controlled study of botulinum toxin A in chronic myofascial painNeurology, 2006
- Expanding use of botulinum toxinJournal of the Neurological Sciences, 2005
- Pharmacologic interventions in the treatment of temporomandibular disorders, atypical facial pain, and burning mouth syndrome. A qualitative systematic review.2003
- The use of botulinum toxin for the treatment of temporomandibular disorder.1998
- Research diagnostic criteria for temporomandibular disorders: review, criteria, examinations and specifications, critique.1992